Algalif, the Icelandic producer of pure, high-grade, natural astaxanthin from microalgae, has announced the expansion of its manufacturing capabilities to increase downstream capacity and facilitate the development of new algae ingredients and novel product formats.
The news follows on from the launch on a range of premium natural astaxanthin soft gelatin capsules, branded IceCaps, that are supplied in bulk for private label applications.
The upgrades to its facilities and installation of new spray-drying equipment enable Algalif to supply premium whole-algae biomass ingredients. The process improvements also help ensure that the quality, stability and efficacy of the astaxanthin is well maintained over time.
Orri Björnsson, Algalif CEO, commented: “These investments and expanded manufacturing capabilities reflect Algalif’s ongoing commitment to quality development and process improvement, and its innovation in delivering a wide range of quality algae ingredients."
Through its facility expansion, Algalif continues to position itself as a leader in algae innovation and research.
In addition, the company also received grants from The Icelandic Centre for Research’s Technology Development Fund and the European Union’s SME Instrument programme to help further its ongoing, advanced research on leading-edge algae forms, production methods and applications.
